Sharon Yang

Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy

B. Hann, D. Sheppard, R. Akhurst, 2021, Cell reports.

Integrin αvβ8 on T cells is responsible for suppression of anti-tumor immunity in multiple syngeneic models and is a promising target for tumor immunotherapy

B. Hann, D. Sheppard, R. Akhurst, 2020, bioRxiv.

Preclinical Pharmacologic Evaluation of MST-997, an Orally Active Taxane with Superior In vitro and In vivo Efficacy in Paclitaxel- and Docetaxel-Resistant Tumor Models

Deepak Sampath, Carol Rios, D. Sampath, 2006, Clinical Cancer Research.

Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors

J. Bienkowska, P. Rejto, Wenyan Zhong, 2020, BMC Genomics.

Molecular and cellular phenotypic differences distinguish murine syngeneic models from human tumors

J. Bienkowska, P. Rejto, Wenyan Zhong, 2019, bioRxiv.

Integrin αvβ8 on T Cells is Responsible for Suppression of Anti-Tumor Immunity in Syngeneic Models and is a Promising Target for Tumor Immunotherapy

B. Hann, D. Sheppard, R. Akhurst, 2020 .

Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential.

J. Glanville, Janet E. Paulsen, L. Bloom, 2013, Journal of molecular biology.